LOGIN  |  REGISTER
Viking Therapeutics
Chimerix

Great Elm Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results

August 29, 2024 | Last Trade: US$1.80 0.00 0.00

PALM BEACH GARDENS, Fla., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Great Elm Group, Inc. (“we,” “our,” “GEG,” “Great Elm,” or “the Company”), (NASDAQ: GEG), an alternative asset manager, today announced financial results for its fiscal fourth quarter and year ended June 30, 2024. 

Fiscal Fourth Quarter 2024 and Recent Highlights

  • Great Elm Capital Corp. (“GECC”) raised $34 million of additional debt and equity capital since April 2024.
  • Fee-paying assets under management (“FPAUM”) and assets under management (“AUM”) both increased 6% in the quarter.
  • Pro forma FPAUM1 and AUM1, inclusive of net proceeds from GECC’s July capital raise, totaled approximately $546 million and $749 million, respectively.
    • Represents pro forma FPAUM1 and AUM1 growth of 11% and 9%, respectively, from March 31, 2024.
  • Total revenue for the fourth quarter approximately tripled to $8.9 million, compared to $3.0 million for the prior-year period.
    • Monomoy BTS closed the sale of its first build-to-suit property in June, generating over $6 million in revenue and over $1 million in profit.
  • Net loss from continuing operations was ($0.6) million for the fourth quarter, compared to ($5.3) million in the prior year period.
    • Net loss for the quarter included ($1.1) million in unrealized loss on GEG’s investment in Prosper Peak Holdings, LLC (“PPH”).
  • Adjusted EBITDA for the fourth quarter was $1.2 million, compared to $0.4 million in the prior-year period.
  • As of June 30, 2024, GEG had approximately $58 million of cash and marketable securities on its balance sheet to support growth initiatives across its alternative asset management platform.
  • GEG repurchased 1.2 million shares for $2.1 million during the quarter through its share repurchase program.
  • GEG repurchased $4.2 million principal of its 5% convertible notes due 2030 for $2.1 million, or approximately 47% of face value, resulting in a realized gain of $2.3 million.

Full Fiscal Year 2024 Highlights

  • GECC raised over $92 million of new capital through July 2024, positioning GEG to further grow management and incentive fee revenue.
    • Great Elm supported GECC’s June and February equity raises of $12 million and $24 million, respectively, by investing a total of $9 million across two separate SPVs that purchased GECC common shares.
  • FPAUM and AUM increased 17% and 14%, respectively, from June 30, 2023.
  • Pro forma FPAUM1 and AUM1, inclusive of net proceeds from GECC’s July 2024 capital raise, increased 22% and 17%, respectively, from June 30, 2023.
  • Great Elm collected incentive fees totaling approximately $2.7 million for the fiscal year ended June 30, 2024.
  • Total revenue for the fiscal year more than doubled to $17.8 million, compared to $8.7 million for fiscal 2023, as a result of the significant build-to-suit property sale and growth in management and incentive fee revenue from credit and real estate businesses.
  • Net loss for the fiscal year from continuing operations was ($0.9) million, compared to net income from continuing operations of $14.5 million in the prior year.
    • Fiscal year 2024 net loss included ($3.8) million in unrealized losses on GEG’s investments in Great Elm Strategic Partnership I, LLC (“GESP”) and PPH.
    • Fiscal year 2023 net income was primarily driven by gain on sale of Forest Investments, Inc.
  • Adjusted EBITDA of $4.8 million for the fiscal year ended June 30, 2024, compared to $1.0 million in fiscal 2023.
  • Great Elm launched Great Elm Credit Income Fund LLC, a private credit fund, in November 2023.
  • Great Elm launched Monomoy BTS Construction Management, LLC, a consulting business providing owner representative services to key clients.

Management Commentary

Jason Reese, Chief Executive Officer of the Company, stated, “We made considerable progress throughout fiscal 2024 in all facets of our business. GECC raised over $90 million of new capital from February to July 2024, due in large part to the innovative joint venture structure we established with experienced, institutional partners. We significantly boosted our fee revenue with growth in incentive fee revenue from GECC as well as increased management fees from our credit and real estate businesses. At Monomoy, our real estate business had outsized performance, driven by the successful sale of our first property and growing pipeline in our Build-to-Suit business. Finally, we launched complementary products and businesses, including a private credit fund and a new construction management consulting business.

Overall, we made great strides during fiscal 2024. Looking ahead to fiscal 2025, we remain focused on further growing our core credit and real estate businesses, sourcing unique investment opportunities, and utilizing our strong balance sheet to expand our platform and create value for our shareholders.”  

Capital Raises to Scale Credit Platform

GECC issued $56.5 million of 8.50% notes due 2029 (“GECCI”). In April 2024, GECC completed an underwritten public offering of $34.5 million of GECCI notes. In July 2024, it issued an additional $22 million in a registered direct offering to an institutional investor.

In June 2024, GECC raised $12 million of equity capital at net asset value from PPH, an SPV that purchased GECC common stock at net asset value. This investment was supported by a $3 million investment by GEG into PPH, with other institutional investors contributing $9 million.

In February 2024, GECC raised $24 million of equity capital from GESP that acquired GECC common stock at net asset value. GEG supported the capital raise by making a $6 million investment into the SPV alongside a large institutional investor that invested $18 million.

Discussion of Financial Results for the Fiscal Fourth Quarter Ended June 30, 2024

GEG reported total revenue of $8.9 million, approximately triple that of $3.0 million in the prior-year period. The increase in revenue was primarily driven by Monomoy BTS’s first build-to-suit property sale.

GEG recorded net loss from continuing operations of ($0.6) million, compared to ($5.3) million in the prior-year period. Included in net loss was ($1.1) million unrealized loss on our investment in PPH during the quarter.

GEG recorded Adjusted EBITDA of $1.2 million, compared to $0.4 million in the prior-year period.

Discussion of Financial Results for the Fiscal Year Ended June 30, 2024

Total revenue for the fiscal year ended June 30, 2024 increased 106% to $17.8 million from $8.7 million in the prior fiscal year, primarily driven by the first build-to-suit property sale and increased incentive fees collected from GECC.

For the fiscal year ended June 30, 2024, the Company reported a net loss from continuing operations of ($0.9) million, compared to net income from continuing operations of $14.5 million for fiscal 2023, which was driven by significant gains from the sale of Forest Investments, Inc. Included in net loss for fiscal 2024 was ($3.8) million of unrealized losses on GEG’s investments in GESP and PPH.

Adjusted EBITDA for the fiscal year ended June 30, 2024 was $4.8 million, compared to $1.0 million in the prior fiscal year.

Stock Repurchase Program and Convertible Notes Extinguishment

In the fiscal second quarter, GEG’s Board of Directors approved a stock repurchase program under which GEG is authorized to repurchase up to $10 million in the aggregate of its outstanding common stock in the open market. To date, the Company has repurchased approximately 1.3 million shares for $2.4 million.

In addition, in June 2024, the Company repurchased $4.2 million in principal of 5% convertible notes due February 26, 2030 for $2.1 million, or approximately 47% of face value, resulting in a realized gain of $2.3 million.

Fiscal 2024 Fourth Quarter and Full Year Conference Call & Webcast Information

When:Friday, August 30, 2024, 8:30 a.m. Eastern Time (ET)
Call:All interested parties are invited to participate in the conference call by dialing +1 (877) 407-0752; international callers should dial +1 (201) 389-0912. Participants should enter the Conference ID 13746832 if asked.
Webcast:The conference call will be webcast simultaneously and can be accessed here. A copy of the slide presentation accompanying the conference call, can be found here.

About Great Elm Group, Inc.

Great Elm Group, Inc. (NASDAQ: GEG) is a publicly-traded, alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Great Elm Group, Inc. and its subsidiaries currently manage Great Elm Capital Corp., a publicly-traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments. Great Elm Group, Inc.’s website can be found at www.greatelmgroup.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Statements in this press release that are “forward-looking” statements, including statements regarding expected growth, profitability, acquisition opportunities and outlook involve risks and uncertainties that may individually or collectively impact the matters described herein. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made and represent Great Elm’s assumptions and expectations in light of currently available information.  These statements involve risks, variables and uncertainties, and Great Elm’s actual performance results may differ from those projected, and any such differences may be material. For information on certain factors that could cause actual events or results to differ materially from Great Elm’s expectations, please see Great Elm’s filings with the Securities and Exchange Commission (“SEC”), including its most recent annual report on Form 10-K and subsequent reports on Forms 10-Q and 8-K. Additional information relating to Great Elm’s financial position and results of operations is also contained in Great Elm’s annual and quarterly reports filed with the SEC and available for download at its website www.greatelmgroup.com or at the SEC website www.sec.gov.

Non-GAAP Financial Measures

The SEC has adopted rules to regulate the use in filings with the SEC, and in public disclosures, of financial measures that are not in accordance with US GAAP, such as adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”). Adjusted EBITDA is derived from methodologies other than in accordance with US GAAP. Great Elm believes that Adjusted EBITDA is an important measure for investors to use in evaluating Great Elm’s businesses. In addition, Great Elm’s management reviews Adjusted EBITDA as they evaluate acquisition opportunities.

Adjusted EBITDA has limitations as an analytical tool, and you should not consider it either in isolation from, or as a substitute for, analyzing Great Elm’s results as reported under US GAAP. Non-GAAP financial measures reported by Great Elm may not be comparable to similarly titled amounts reported by other companies.

Included in the financial tables below is a reconciliation of Adjusted EBITDA to the most directly comparable US GAAP financial measure, net income from continuing operations.

Endnotes
1 Pro forma FPAUM assumes full investment of incremental capital.

Media & Investor Contact:
Investor Relations
This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Great Elm Group, Inc.
Condensed Consolidated Balance Sheets
Dollar amounts in thousands (except per share data)

ASSETS June 30, 2024  June 30, 2023 
Current assets      
Cash and cash equivalents $48,147  $60,165 
Restricted cash  1,571   - 
Receivables from managed funds  2,259   3,308 
Investments in marketable securities  9,929   24,595 
Investments, at fair value (cost $54,261 and $40,387, respectively)  44,585   32,611 
Prepaid and other current assets  1,215   717 
Real estate under development  5,769   1,742 
Assets of Consolidated Funds:      
Cash and cash equivalents  2,371   - 
Investments, at fair value (cost $11,338)  11,471   - 
Other assets  253   - 
Total current assets  127,570   123,138 
Identifiable intangible assets, net  11,037   12,115 
Right-of-use assets  225   497 
Other assets  1,614   143 
Total assets $140,446  $135,893 
LIABILITIES AND STOCKHOLDERS' EQUITY      
Current liabilities      
Accounts payable $317  $191 
Accrued expenses and other current liabilities  7,009   5,418 
Current portion of related party payables  634   1,409 
Current portion of lease liabilities  137   359 
Liabilities of Consolidated Funds:        
Payable for securities purchased  100   - 
Accrued expenses and other liabilities  162   - 
Total current liabilities  8,359   7,377 
Lease liabilities, net of current portion  57   142 
Long-term debt (face value $26,945)  26,090   25,808 
Related party payables, net of current portion  -   926 
Convertible notes (face value $35,494 and $37,912, including $16,174 and $15,395 held by related parties, respectively)  34,900   37,129 
Other liabilities  845   669 
Total liabilities  70,251   72,051 
Commitments and contingencies      
Stockholders' equity      
Preferred stock, $0.001 par value; 5,000,000 authorized and zero outstanding  -   - 
Common stock, $0.001 par value; 350,000,000 shares authorized and 31,875,285 shares issued and 30,494,448 outstanding at June 30, 2024; and 30,651,047 shares issued and 29,546,655 outstanding at June 30, 2023  30   30 
Additional paid-in-capital  3,315,638   3,315,378 
Accumulated deficit  (3,252,954)  (3,251,566)
Total Great Elm Group, Inc. stockholders' equity  62,714   63,842 
Non-controlling interests  7,481   - 
Total stockholders' equity  70,195   63,842 
Total liabilities and stockholders' equity $140,446  $135,893 

Great Elm Group, Inc.
Condensed Consolidated Statements of Operations
Amounts in thousands (except per share data)

  For the three months ended
June 30,
  For the twelve months ended
June 30,
 
  2024  2023  2024  2023 
Revenues $8,918  $3,026  $17,834  $8,663 
Cost of revenues 5,526  -  5,526  - 
Operating costs and expenses:            
Investment management expenses  2,997   3,303   11,331   10,196 
Depreciation and amortization  271   282   1,108   1,152 
Selling, general and administrative  1,916   3,039   7,654   8,480 
Expenses of Consolidated Funds  31   -   53   46 
Total operating costs and expenses  5,215   6,624   20,146   19,874 
Operating loss  (1,823)  (3,598)  (7,838)  (11,211)
Dividends and interest income  1,640   1,777   8,057   6,209 
Net realized and unrealized gain (loss) on investments  477   (2,187)  2,212   15,247 
Net realized and unrealized (loss) gain on investments of Consolidated Funds  (12)  -   233   (16)
Interest and other income of Consolidated Funds  378   -   829   - 
Gain on sale of controlling interest in subsidiary  -   -   -   10,524 
Interest expense  (1,137)  (1,050)  (4,334)  (6,074)
(Loss) income before income taxes from continuing operations  (477)  (5,058)  (841)  14,679 
Income tax benefit (expense)  (101)  (198)  (101)  (200)
Net (loss) income from continuing operations  (578)  (5,256)  (942)  14,479 
Discontinued operations:            
Net income from discontinued operations  -   (1)  16   13,201 
Net (loss) income $(578) $(5,257) $(926) $27,680 
Less: net income (loss) attributable to non-controlling interest, continuing operations  -   -   462   (1,554)
Less: net income attributable to non-controlling interest, discontinued operations  -   -   -   1,504 
Net (loss) income attributable to Great Elm Group, Inc. $(578) $(5,257) $(1,388) $27,730 
Basic net (loss) income per share from:            
Continuing operations $(0.02) $(0.18) $(0.05) $0.55 
Discontinued operations  -   -   -   0.40 
Basic net (loss) income per share $(0.02) $(0.18) $(0.05) $0.95 
Diluted net (loss) income per share from:            
Continuing operations $(0.02) $(0.18) $(0.05) $0.44 
Discontinued operations  -   -   -   0.29 
Diluted net (loss) income per share $(0.02) $(0.18) $(0.05) $0.73 
Weighted average shares outstanding            
Basic  30,318   29,303   29,962   28,910 
Diluted  30,318   29,303   29,962   40,980 

Great Elm Group, Inc.
Reconciliation from Net Income (Loss) from Continuing Operations to Adjusted EBITDA
Dollar amounts in thousands

  Three months ended June 30,  Twelve months ended June 30, 
(in thousands) 2024  2023 2024  2023
Net income (loss) from continuing operations - GAAP $(578)  $(5,256) $(942)  $14,479 
Interest expense  1,137    1,050   4,334    6,074 
Income tax expense (benefit)  101    198   101    200 
Depreciation and amortization  271    282   1,108    1,152 
Non-cash compensation  688    701   3,112    2,948 
(Gain) loss on investments  (465)   2,187   (2,445)   9,167 
Gains related to sale of Forest  -    -   -    (34,922)
Transaction and integration related costs(1)  -    634   -    1,105 
Change in contingent consideration  20    603   (498)   783 
Adjusted EBITDA(2) $1,174   $399  $4,770   $986 

(1) Transaction and integration-related costs include costs to sell, acquire and integrate acquired businesses.
(2) Adjusted EBITDA for prior periods has been adjusted to include dividend income earned during such periods consistent with the methodology for June 30, 2024.

Terns Pharmaceuticals

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB